Sigal Fattal
Director Financiero/CFO en CHEMOMAB THERAPEUTICS LTD. .
Fortuna: 494 $ al 30/04/2024
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Adi Mor | M | 43 | 13 años | |
Nissim Darvish | M | 59 | 3 años | |
Neil Cohen | M | 60 | 4 años | |
Claude Nicaise | M | 71 | 3 años | |
Jonathan Solomon | M | 47 |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | 7 años |
Alan Moses | M | 76 | 3 años | |
Barbara Lindheim | F | - | - | |
Merav Bassan | M | 59 |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | 5 años |
Ilan Vaknin | M | - | 2 años | |
Liat Foigel Wejgman | F | - | 9 años | |
Jack Lawler | M | - | 2 años | |
Sharon Hashmueli | M | - | 8 años | |
Jill Quigley | F | 49 | 2 años | |
Russell Greig | M | 71 |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | 5 años |
Robert Woodman | M | 46 |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | 6 años |
Jonas Grossman | M | 50 |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | 5 años |
Matthew B. Frankel | M | 56 | 2 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Dale Pfost | M | - | 2 años | |
Stephen P. Squinto | M | 67 | - | |
Ziv Kop | M | 53 | - | |
Sharon Elkobi | F | - | 3 años | |
Joel Maryles | M | 64 | 1 años | |
Akiva Mozes | M | 77 | - | |
Donald Marvin | M | - | 2 años | |
Efrat Makov | F | 56 | 2 años | |
Assaf Oron | M | 49 |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | 2 años |
Mitchell Jones | M | 46 | - | |
Raf Hofstein | M | 74 | 12 años | |
Gbola Amusa | M | 50 |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | 1 años |
Erez Chimovits | M | 60 |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | 3 años |
Eyal Leibovitz | M | 63 | 1 años | |
Yaron Breski | M | 46 |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | 1 años |
Timothy Lu | M | 43 |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | 4 años |
Arnon Aharon | M | 55 | 5 años | |
David Weiner | M | 59 | 1 años | |
Sailaja Puttagunta | M | 55 |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | 1 años |
Michal Segal-Salto | M | 51 | 7 años |
Estadísticas
País | Relaciones | % del total |
---|---|---|
Israel | 37 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Sigal Fattal
- Red Personal